Insights Into Urothelial Cancer 2024

Perspectives on drivers in treatment decisions in the management of urothelial cancer

Northeast – August 24, 2024
Purchase Report

Faculty Chair

David Aggen, MD, PhD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

More Information

  • Philadelphia, PA
  • Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of urothelial cancer
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert

GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in Insights Into Urothelial Cancer 2024.

Complete the form below to receive additional information.